58 related articles for article (PubMed ID: 24729451)
1. Multiple effects of the special AT-rich binding protein 1 (SATB1) in colon carcinoma.
Frömberg A; Rabe M; Aigner A
Int J Cancer; 2014 Dec; 135(11):2537-46. PubMed ID: 24729451
[TBL] [Abstract][Full Text] [Related]
2. SATB1 overexpression regulates the development and progression in bladder cancer through EMT.
Wan F; Cheng C; Wang Z; Xiao X; Zeng H; Xing S; Chen X; Wang J; Li S; Zhang Y; Xiang W; Zhu Z; Johnson C; Zhu Z
PLoS One; 2015; 10(2):e0117518. PubMed ID: 25706386
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of SATB1 is associated with biologic behavior in human renal cell carcinoma.
Cheng C; Wan F; Liu L; Zeng F; Xing S; Wu X; Chen X; Zhu Z
PLoS One; 2014; 9(5):e97406. PubMed ID: 24835085
[TBL] [Abstract][Full Text] [Related]
4. Satb1 integrates DNA binding site geometry and torsional stress to differentially target nucleosome-dense regions.
Ghosh RP; Shi Q; Yang L; Reddick MP; Nikitina T; Zhurkin VB; Fordyce P; Stasevich TJ; Chang HY; Greenleaf WJ; Liphardt JT
Nat Commun; 2019 Jul; 10(1):3221. PubMed ID: 31324780
[TBL] [Abstract][Full Text] [Related]
5. Retraction: SATB1 Overexpression Regulates the Development and Progression in Bladder Cancer through EMT.
PLOS ONE Editors
PLoS One; 2024; 19(4):e0301572. PubMed ID: 38564501
[No Abstract] [Full Text] [Related]
6. Retraction: Overexpression of SATB1 Is Associated with Biologic Behavior in Human Renal Cell Carcinoma.
PLOS ONE Editors
PLoS One; 2024; 19(4):e0301571. PubMed ID: 38564511
[No Abstract] [Full Text] [Related]
7. SATB1 and 2 in colorectal cancer.
Brocato J; Costa M
Carcinogenesis; 2015 Feb; 36(2):186-91. PubMed ID: 25543122
[TBL] [Abstract][Full Text] [Related]
8. Expression of SATB1 promotes the growth and metastasis of colorectal cancer.
Zhang Y; Tian X; Ji H; Guan X; Xu W; Dong B; Zhao M; Wei M; Ye C; Sun Y; Yuan X; Yang C; Hao C
PLoS One; 2014; 9(6):e100413. PubMed ID: 24971456
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Significance of TLR2, SMAD3 and Localization-dependent SATB1 in Stage I and II Non-Small-Cell Lung Cancer Patients.
Durślewicz J; Klimaszewska-Wiśniewska A; Jóźwicki J; Antosik P; Smolińska-Świtała M; Gagat M; Kowalewski A; Grzanka D
Cancer Control; 2021; 28():10732748211056697. PubMed ID: 34818944
[TBL] [Abstract][Full Text] [Related]
10. SATB1 protein is associated with the epithelial‑mesenchymal transition process in non‑small cell lung cancers.
Glatzel-Plucinska N; Piotrowska A; Rzechonek A; Podhorska-Okolow M; Dziegiel P
Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33955522
[TBL] [Abstract][Full Text] [Related]
11. Tackling tumor microenvironment through epigenetic tools to improve cancer immunotherapy.
Lodewijk I; Nunes SP; Henrique R; Jerónimo C; Dueñas M; Paramio JM
Clin Epigenetics; 2021 Mar; 13(1):63. PubMed ID: 33761971
[TBL] [Abstract][Full Text] [Related]
12. SATB1 Knockdown Inhibits Proliferation and Invasion and Decreases Chemoradiation Resistance in Nasopharyngeal Carcinoma Cells by Reversing EMT and Suppressing MMP-9.
Zhou D; Ye C; Pan Z; Deng Y
Int J Med Sci; 2021; 18(1):42-52. PubMed ID: 33390772
[No Abstract] [Full Text] [Related]
13. SATB1-Mediated Upregulation of the Oncogenic Receptor Tyrosine Kinase HER3 Antagonizes MET Inhibition in Gastric Cancer Cells.
Jenke R; Holzhäuser-Rein M; Mueller-Wilke S; Lordick F; Aigner A; Büch T
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374770
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticle-complexed antimiRs for inhibiting tumor growth and metastasis in prostate carcinoma and melanoma.
Kunz M; Brandl M; Bhattacharya A; Nobereit-Siegel L; Ewe A; Weirauch U; Hering D; Reinert A; Kalwa H; Guzman J; Weigelt K; Wach S; Taubert H; Aigner A
J Nanobiotechnology; 2020 Nov; 18(1):173. PubMed ID: 33228711
[TBL] [Abstract][Full Text] [Related]
15. Involvement of Actin and Actin-Binding Proteins in Carcinogenesis.
Izdebska M; Zielińska W; Hałas-Wiśniewska M; Grzanka A
Cells; 2020 Oct; 9(10):. PubMed ID: 33036298
[TBL] [Abstract][Full Text] [Related]
16. SATB1 as oncogenic driver and potential therapeutic target in head & neck squamous cell carcinoma (HNSCC).
Panchal O; Wichmann G; Grenman R; Eckhardt L; Kunz-Schughart LA; Franke H; Dietz A; Aigner A
Sci Rep; 2020 May; 10(1):8615. PubMed ID: 32451408
[TBL] [Abstract][Full Text] [Related]
17. The Role of lncRNAs TAPIR-1 and -2 as Diagnostic Markers and Potential Therapeutic Targets in Prostate Cancer.
Friedrich M; Wiedemann K; Reiche K; Puppel SH; Pfeifer G; Zipfel I; Binder S; Köhl U; Müller GA; Engeland K; Aigner A; Füssel S; Fröhner M; Peitzsch C; Dubrovska A; Rade M; Christ S; Schreiber S; Hackermüller J; Lehmann J; Toma MI; Muders MH; Sommer U; Baretton GB; Wirth M; Horn F
Cancers (Basel); 2020 Apr; 12(5):. PubMed ID: 32365858
[TBL] [Abstract][Full Text] [Related]
18. The Role of SATB1 in Tumour Progression and Metastasis.
Glatzel-Plucińska N; Piotrowska A; Dzięgiel P; Podhorska-Okołów M
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450715
[TBL] [Abstract][Full Text] [Related]
19. Prognostic and Clinicopathological Significance of SATB1 in Colorectal Cancer: A Meta-Analysis.
Zhao J; Tuo Y; Luo W; He S; Chen Y
Front Physiol; 2018; 9():535. PubMed ID: 29867574
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
